Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1427.85 -0.55 (-0.04%) | NSE 1443.80 14.50 (1.01%) | Trade | Add

BSE Live

Dec 03, 16:02

1427.85 -0.55 (-0.04%)

Volume

AVERAGE VOLUME

5-Day

123,216

10-Day

76,686

30-Day

41,394

4,869

Prev. Close

1428.40
Open Price

1435.30

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 03, 15:57

1443.80 14.50 (1.01%)

Volume

AVERAGE VOLUME

5-Day

203,420

10-Day

211,377

30-Day

343,185

148,078

Prev. Close

1429.30
Open Price

1439.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1443.80 (565)

Financials

Print/Copy to Excel : Go

Balance Sheet of Ipca Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.37	25.37	25.37	25.37	25.37
Total Share Capital	25.37	25.37	25.37	25.37	25.37
Reserves and Surplus	6,923.08	6,306.82	5,816.65	5,466.60	4,676.28
Total Reserves and Surplus	6,923.08	6,306.82	5,816.65	5,466.60	4,676.28
Total Shareholders Funds	6,948.45	6,332.19	5,842.02	5,491.97	4,701.65
Minority Interest	1,439.82	1,394.81	73.30	76.92	14.53
NON-CURRENT LIABILITIES
Long Term Borrowings	543.24	580.41	651.78	395.18	9.13
Deferred Tax Liabilities [Net]	294.97	310.47	189.16	152.58	133.55
Other Long Term Liabilities	51.54	40.92	17.36	13.60	10.40
Long Term Provisions	96.31	86.84	46.99	42.73	38.56
Total Non-Current Liabilities	986.06	1,018.64	905.29	604.09	191.64
CURRENT LIABILITIES
Short Term Borrowings	758.46	807.09	805.75	396.06	243.21
Trade Payables	846.17	776.08	525.06	557.70	664.86
Other Current Liabilities	512.42	527.91	366.98	410.60	149.33
Short Term Provisions	269.17	244.56	108.03	101.52	103.14
Total Current Liabilities	2,386.22	2,355.64	1,805.82	1,465.88	1,160.54
Total Capital And Liabilities	11,760.55	11,101.28	8,626.43	7,638.86	6,068.36
ASSETS
NON-CURRENT ASSETS
Tangible Assets	4,068.91	4,339.51	2,572.41	2,208.75	1,962.79
Intangible Assets	107.06	123.30	140.83	154.61	63.04
Capital Work-In-Progress	616.17	323.59	122.17	293.85	183.66
Fixed Assets	4,798.00	4,805.84	2,853.67	2,669.79	2,260.65
Non-Current Investments	216.32	303.61	302.66	269.88	111.43
Deferred Tax Assets [Net]	16.92	4.23	3.57	2.02	1.95
Long Term Loans And Advances	32.35	88.59	115.90	71.40	139.47
Other Non-Current Assets	337.84	269.53	123.22	114.44	71.30
Total Non-Current Assets	5,492.01	5,562.38	3,437.16	3,181.69	2,631.40
CURRENT ASSETS
Current Investments	763.39	558.40	323.32	719.31	393.83
Inventories	2,560.42	2,471.31	1,743.37	1,857.97	1,594.81
Trade Receivables	1,873.82	1,686.51	989.02	910.78	811.75
Cash And Cash Equivalents	344.23	296.84	1,853.24	640.66	365.07
Short Term Loans And Advances	42.76	9.40	3.23	10.34	2.47
OtherCurrentAssets	683.92	516.44	277.09	318.11	269.03
Total Current Assets	6,268.54	5,538.90	5,189.27	4,457.17	3,436.96
Total Assets	11,760.55	11,101.28	8,626.43	7,638.86	6,068.36
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	613.89	303.44	2,125.64	274.03	369.48
BONUS DETAILS
Bonus Equity Share Capital	10.45	10.45	10.45	10.45	20.90
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	219.14	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	182.55	146.59	172.85	155.19	34.17
CURRENT INVESTMENTS
Current Investments Quoted Market Value	763.39	558.40	323.32	719.31	393.83
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00